Poonam Kumari Opposition, Lenacapavir, (201917006277)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
LOW COST STANDARD THERAPEUTICS opposition, TAF/FTC, (201817001590)
Countries: India Date: 2023
-
Thai Network of People Living with HIV/AIDS (TNP+) opposition, Lenacapavir, (WO/2014/134566)
Countries: Thailand Date: 2023
-
Thai Network of People Living with HIV/AIDS (TNP+) opposition, Lenacapavir, (PCT/US2017/047416)
Countries: Thailand Date: 2023
-
Balaji R opposition, Elexacaftor, (201737015848)
Countries: India Date: 2023
-
Sankalp Rehabilitation Trust opposition, Quabodepistat, (201737004817)
Countries: India Date: 2023
-
Sankalp Rehabilitation Trust opposition, Bedaquiline Long Acting, (202017005443)
Countries: India Date: 2023
-
DR. C. MANIVANNAN opposition, Upadacitinib [RINVOQ], (4759/DELNP/2012)
Countries: India Date: 2023
-
NEHA SAHU opposition, Upadacitinib [RINVOQ], (4759/DELNP/2012)
Countries: India Date: 2023
-
Dr. C. Manivannan opposition, Tirzepatide, ( 202017050717)
Countries: India Date: 2023
-
Mylan Laboratories India opposition, Raltegravir, (4187/DELNP/2007)
Countries: India Date: 2018